Download PDF
Suchttherapie 2014; 15(01): 29-34
DOI: 10.1055/s-0033-1357187
Schwerpunktthema
© Georg Thieme Verlag KG Stuttgart · New York

Komorbidität von bipolar affektiven Störungen und Alkoholabhängigkeit: Häufigkeit, Konsequenzen und Therapiemöglichkeiten

Comorbidity of Bipolar Affective Disorders and Alcohol Dependence: Frequency, Consequences and Treatment
U. W. Preuss
1   KKH Prignitz, akademisches Lehrkrankenhaus, Klinik für Psychiatrie, Psychotherapie und Psychosomatik
,
J.W. M. Wong
1   KKH Prignitz, akademisches Lehrkrankenhaus, Klinik für Psychiatrie, Psychotherapie und Psychosomatik
,
F. M. Wurst
2   Universitätsklinik für Psychiatrie und Psychotherapie II, Christian-Doppler-Klinik, SALK, Paracelsus Medical University (PMU), Salzburg, Österreich
› Author Affiliations
Further Information

Publication History

Publication Date:
12 December 2013 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Alkohol- und Substanzmittelkonsumstörungen, wie die Abhängigkeit und der schädliche Konsum zählen zu den häufigsten komorbiden Krankheitsbildern bei bipolaren Patienten. Diese komorbiden Störungen haben wechselseitig einen signifikanten Einfluss auf die Schwere der jeweils anderen Erkrankung und die Prognose.

Eine Reihe von Studien bei Betroffenen mit dieser Komorbidität wurden in den letzten Jahren publiziert. Dazu zählen doppelblinde, kontrollierte Untersuchungen zu Pharmaka ebenso wie der Einsatz von psychotherapeutischen Verfahren in 2 Studien.

Ergebnisse hinsichtlich einer kombinierten Therapie, die auch prospektiv vorliegen, liefern Hinweise auf die Möglichkeiten und Grenzen kombinierter und integrierter Therapien bei Personen mit Alkoholkonsumstörungen und bipolaren ­Erkrankungen.

Abstract

Alcohol use disorders (AUD), just like dependence and hazardous use, are frequently seen as comorbid conditions in bipolar affective disorders (BAS). These comorbid disorders significantly influence the severity and prognosis of each other.

A number of studies in comorbid individuals with alcohol dependence and bipolar disorders were published in recent years. These include placebo-controlled clinical trials testing efficacy of several medications as well as treatment with psychotherapeutic approaches. The cross-section and prospective results highlight the strengths and limitations of combined/integrated approaches in treatment of comorbid bipolar and alcohol-dependent persons.

Schlüsselwörter

Komorbidität - Alkoholabhängigkeit - bipolare Störungen - Pharmakotherapie - Psychotherapie

Key words

comorbidity - alcohol dependence - bipolar disorder - pharmacotherapy - psychotherapy
 

  • Literatur

  • 1 Angst J. Bipolar disorder – methodological problems and future perspectives. Dialogues Clin Neurosci 2008; 10: 129-139
    PubMedGoogle Scholar
  • 2 Angst J, Gamma A, Benazzi F et al. Diagnostic issues in bipolar disorder. Eur Neuropsychopharmacol 2003; 13 (Suppl 2) S43-S50
    CrossrefPubMedGoogle Scholar
  • 3 Cardoso BM, Kauer-Sant’Anna M, Dias VV et al. The impact of co-morbid alcohol use disorder in bipolar patients. Alcohol 2008; 42: 451-457
    CrossrefPubMedGoogle Scholar
  • 4 Oquendo MA, Currier D, Liu SM et al. Increased risk for suicidal behavior in comorbid bipolar disorder and alcohol use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). J Clin Psychiatry 2010; 71: 902-909
    CrossrefPubMedGoogle Scholar
  • 5 Cassidy F, Ahearn EP, Carroll BJ. Substance abuse in bipolar disorder. Bipolar Disord 2001; 3: 181-188
    CrossrefPubMedGoogle Scholar
  • 6 Farren CK, McElroy S. Predictive factors for relapse after an integrated inpatient treatment programme for unipolar depressed and bipolar alcoholics. Alcohol Alcohol 2010; 45: 527-533
    CrossrefPubMedGoogle Scholar
  • 7 Regier DA, Farmer ME, Rae DS et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 1990; 264: 2511-2518
    CrossrefPubMedGoogle Scholar
  • 8 Grant BF, Hasin DS, Stinson FS et al. Co-occurrence of 12-month mood and anxiety disorders and personality disorders in the US: results from the national epidemiologic survey on alcohol and related conditions. J Psychiatr Res 2005; 39: 1-9
    CrossrefPubMedGoogle Scholar
  • 9 Ostacher MJ, Perlis RH, Nierenberg AA et al. STEP-BD Investigators. Impact of substance use disorders on recovery from episodes of depression in bipolar disorder patients: prospective data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry 2010; 167: 289-297
    CrossrefPubMedGoogle Scholar
  • 10 Kessler RC, McGonagle KA, Zhao S et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994; 51: 8-19
    Google Scholar
  • 11 Sonne SC, Brady T. Bipolar Disorders and Alcoholism. Alcohol Research Health 2002; 26: 103-108
    PubMedGoogle Scholar
  • 12 Soyka M. Substance misuse, psychiatric disorder and violent and disturbed behaviour. Br J Psychiatry 2000; 176: 345-350
    CrossrefPubMedGoogle Scholar
  • 13 Feinman JA, Dunner DL. The effect of alcohol and substance abuse on the course of bipolar affective disorder. J Affect Disord 1996; 12; 37: 43-49
    PubMedGoogle Scholar
  • 14 Prisciandaro JJ, DeSantis SM, Chiuzan C et al. Impact of depressive symptoms on future alcohol use in patients with co-occurring bipolar disorder and alcohol dependence: a prospective analysis in an 8-week randomized controlled trial of acamprosate. Alcohol Clin Exp Res 2012; 36: 490-496
    CrossrefPubMedGoogle Scholar
  • 15 Strakowski SM, DelBello MP, Fleck DE et al. Effects of co-occurring alcohol abuse on the course of bipolar disorder following a first hospitalization for mania. Arch Gen Psychiatry 2005; 62: 851-858
    CrossrefPubMedGoogle Scholar
  • 16 Salloum IM, Thase ME. Impact of substance abuse on the course and treatment of bipolar disorder. Bipolar Disord 2000; 2: 269-280
    CrossrefPubMedGoogle Scholar
  • 17 American Psychiatric Association . Am J. Psychiatry 2002; 159: 1-50
    PubMed
  • 18 Brady KT, Verduin ML, Tolliver BK. Treatment of patients comorbid for addiction and other psychiatric disorders. Curr Psychiatry Rep 2007; 9: 374-380
    CrossrefPubMedGoogle Scholar
  • 19 Swann AC, Dougherty DM, Pazzaglia PJ et al. Increased impulsivity associated with severity of suicide attempt history in patients with bipolar disorder. Am J Psychiatry 2005; 162: 1680-1687
    CrossrefPubMedGoogle Scholar
  • 20 Cerullo MA, Strakowski SM. The prevalence and significance of substance use disorders in bipolar type I and II disorder. Subst Abuse Treat Prev Policy 2007; 2: 29
    CrossrefPubMedGoogle Scholar
  • 21 Salloum IM, Cornelius JR, Daley DC et al. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study. Arch Gen Psychiatry 2005; 62: 37-45
    CrossrefPubMedGoogle Scholar
  • 22 Brown ES, Jeffress J, Liggin JD et al. Switching outpatients with bipolar or schizoaffective disorders and substance abuse from their current antipsychotic to aripiprazole. J Clin Psychiatry 2005; 66: 756-760
    CrossrefPubMedGoogle Scholar
  • 23 Brown ES, Garza M, Carmody TJ. A randomized, double-blind, placebo-controlled add on trial of quetiapine in outpatients with bipolar disorder and alcohol use disorders. J Clin Psychiatry 2008; 69: 701-705
    CrossrefPubMedGoogle Scholar
  • 24 Stedman M, Pettinati HM, Brown ES et al. A double-blind, placebo-controlled study with quetiapine as adjunct therapy with lithium or divalproex in bipolar I patients with coexisting alcohol dependence. Alcohol Clin Exp Res 2010; 34: 1822-1831
    CrossrefPubMedGoogle Scholar
  • 25 Petrakis IL, Poling J, Levinson C et al. VA New England VISN I MIRECC Study Group. Naltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders. Biol Psychiatry 2005; 57: 1128-1137
    Google Scholar
  • 26 Brown ES, Beard L, Dobbs L et al. Naltrexone in patients with bipolar disorder and alcohol dependence. Depress Anxiety 2006; 23: 492-495
    CrossrefPubMedGoogle Scholar
  • 27 Brown ES, Carmody TJ, Schmitz JM et al. A randomized, double-blind, placebo controlled pilot study of naltrexone in outpatients with bipolar disorder and alcohol dependence. Alcohol Clin Exp Res 2009; 33: 1863-1869
    CrossrefPubMedGoogle Scholar
  • 28 Tolliver BK, Desantis SM, Brown DG et al. A randomized, double-blind, placebo controlled clinical trial of acamprosate in alcohol-dependent individuals with bipolar disorder: a preliminary report. Bipolar Disord 2012; 14: 54-63
    CrossrefPubMedGoogle Scholar
  • 29 Weiss RD, Griffin ML, Kolodziej ME et al. A randomized trial of integrated group therapy versus group drug counseling for patients with bipolar disorder and substance dependence. Am J Psychiatry 2007; 164: 100-107
    CrossrefPubMedGoogle Scholar
  • 30 Farren CK, Mc Elroy S. Treatment response of bipolar and unipolar alcoholics to an inpatient dual diagnosis program. J Affect Disord 2008; 106: 265-272
    CrossrefPubMedGoogle Scholar
  • 31 Farren CK, Snee L, McElroy S. Gender differences at 2-year follow-up of treated bipolar and depressed alcoholics. J Stud Alc Drugs 2011; 72: 872-880
    PubMedGoogle Scholar
  • 32 Farren CK, Snee L, Daly P et al. Prognostic factors of 2-year outcomes of patients with comorbid bipolar disorder or depression with alcohol dependence: importance of early abstinence. Alcohol Alcohol 2013; 48: 93-98
    CrossrefPubMedGoogle Scholar
  • 33 Drake RE, Xie H, McHugo GJ et al. Three-year outcomes of long-term patients with co-occurring bipolar and substance use disorders. Biol Psychiatry 2004; 56: 749-756
    CrossrefPubMedGoogle Scholar